SCHEMBL7497017

SCHEMBL7497017

CCOC(=O)C1CC(N)(C(=O)OCC)C1

nearest known ligand 0.41

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
MAPT P10636 2/20 0.40
ALDH1A1 P00352 5/20 0.38
CYP1A2 P05177 2/20 0.37
HSD11B1 P28845 1/20 0.36
ALOX15 P16050 2/20 0.35
GAA P10253 2/20 0.35
MGAM O43451 1/20 0.35
SI P14410 1/20 0.35
MGAM2 Q2M2H8 1/20 0.35
KDM4E B2RXH2 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8444385 0.85 CYP1A2 (0.37) CYP3A4CYP2D6CYP2C9CYP2C19MAPT
SCHEMBL4589939 0.85 CYP1A2 (0.37) CYP3A4CYP2D6CYP2C9CYP2C19MAPT
SCHEMBL8501127 0.85 CYP1A2 (0.37) CYP3A4CYP2D6CYP2C9CYP2C19MAPT
SCHEMBL25755453 0.85 ALDH1A1 (0.36) CYP3A4CYP2D6CYP2C9CYP2C19MAPT
SCHEMBL12343942 0.81 ALOX15 (0.38) ALDH1A1CYP1A2ALOX15GAAMGAM
SCHEMBL20605561 0.81 ALOX15 (0.38) ALDH1A1CYP1A2ALOX15GAAMGAM
SCHEMBL3141492 0.81 GAA (0.38) ALDH1A1CYP1A2ALOX15GAAMGAM
Hydrochloric Acid SCHEMBL13276364 0.79 ALOX15 (0.37) ALDH1A1CYP1A2ALOX15GAAMGAM
Hydrochloric Acid SCHEMBL2789388 0.79 ALOX15 (0.37) ALDH1A1CYP1A2ALOX15GAAMGAM
SCHEMBL20139837 0.78 CYP2C19 (0.46) CYP3A4CYP2D6CYP2C9CYP2C19MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0929547-B1 BENZAMIDINE DERIVATIVES SUBSTITUTED BY CYCLIC AMINO ACID OR CYCL IC HYDROXY ACID DERIVATIVES AND THEIR USE AS ANTI-COAGULANTS SCHERING AG (DE) 2002-11-27 EP disclosed
US-6265404-B1 FACTOR X INHIBITOR BERLEX LABORATORIES, INC. 2001-07-24 US disclosed
US-6232325-B1 THROMBOSIS THERAPY BERLEX LABORATORIES, INC. 2001-05-15 US disclosed
US-6177473-B1 FACTOR X INHIBITOR BERLEX LABORATORIES, INC. 2001-01-23 US disclosed
US-6008234-A TREATING A HUMAN HAVING A DISEASE-STATE CHARACTERIZED BY THROMBOTIC ACTIVITY, INHIBITING HUMAN BLOOD COAGULATION FACTOR XA BERLEX LABORATORIES, INC. (US) 1999-12-28 US disclosed